Tags: Drug.
Dronedarone (development codename SR33589 and marketed as Multaq) is a drug by Sanofi-Aventis mainly for the indication of cardiac arrhythmias. It was approved by the FDA on July 2 2009. It was recommended as an alternative to amiodarone for the treatment of atrial fibrillation and atrial flutter in people whose hearts have either returned to normal rhythm or who undergo drug therapy or electric shock treatment i.e. direct current cardioversion (DCCV) to maintain normal rhythm.
